Resveratrol suppresses human glioblastoma cell migration and invasion via activation of RhoA/ROCK signaling pathway

Xiong,Wei; Yin,Anan; Mao,Xinggang; Zhang,Wei; Huang,Huiyong; Zhang,Xiang

doi:10.3892/ol.2015.3888

Resveratrol suppresses human glioblastoma cell migration and invasion via activation of RhoA/ROCK signaling pathway

Authors:
- Wei Xiong
- Anan Yin
- Xinggang Mao
- Wei Zhang
- Huiyong Huang
- Xiang Zhang
View Affiliations

Affiliations: Department of Neurosurgery, Xijing Institute of Clinical Neuroscience, Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China
Published online on: November 6, 2015 https://doi.org/10.3892/ol.2015.3888
Pages: 484-490

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Numerous studies have demonstrated that resveratrol has a potential use in cancer prevention and treatment. However, the effects of resveratrol on cancer cell motility and invasiveness remain unclear. The current study aimed to examine the effects of resveratrol on cell migration and invasion in human glioblastoma cells, and to explore the underlying molecular mechanisms. In wound‑healing and Matrigel transwell assays, resveratrol was found to significantly inhibit the migration and invasion of U87MG, T98G and U251 glioblastoma cells in vitro. Results from western blot analysis and gelatin zymography revealed that resveratrol also suppressed the expression and activity of matrix metalloproteinase 2 (MMP‑2; P<0.05), an important mediator of cell migration and invasion. Furthermore, using a pull‑down assay, increased activation of RhoA was observed in glioblastoma cells treated with resveratrol vs. controls (P<0.05). Notably, inhibition of the RhoA/Rho‑associated kinase (ROCK) pathway by C3 transferase or Y‑27362 was found to attenuate the resveratrol‑induced reductions in cell migration and invasion (P<0.05), and also partially rescued the decreased expression and activity of MMP‑2 induced by resveratrol (P<0.05). Taken together, the results suggest that resveratrol may inhibit glioblastoma cell motility and invasiveness via activating the RhoA/ROCK signaling pathway.

View Figures

View References

1	Taylor JW, Chi AS and Cahill DP: Tailored therapy in diffuse gliomas: Using molecular classifiers to optimize clinical management. Oncology (Williston Park). 27:504–514. 2013.PubMed/NCBI
2	Van Meir EG, Hadjipanayis CG, Norden AD, et al: Exciting new advances in neuro-oncology: The avenue to a cure for malignant glioma. CA Cancer J Clin. 60:166–193. 2010. View Article : Google Scholar : PubMed/NCBI
3	Alves TR, Lima FR, Kahn SA, et al: Glioblastoma cells: A heterogeneous and fatal tumor interacting with the parenchyma. Life Sci. 89:532–539. 2011. View Article : Google Scholar : PubMed/NCBI
4	Munson J, Bonner M, Fried L, et al: Identifying new small molecule anti-invasive compounds for glioma treatment. Cell Cycle. 12:2200–2209. 2013. View Article : Google Scholar : PubMed/NCBI
5	Westermarck J and Kähäri VM: Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 13:781–792. 1999.PubMed/NCBI
6	Kleiner DE and Stetler-Stevenson WG: Matrix metalloproteinases and metastasis. Cancer Chemother Pharmacol. 43(Suppl): S42–S51. 1999. View Article : Google Scholar : PubMed/NCBI
7	Kessenbrock K, Plaks V and Werb Z: Matrix metalloproteinases: Regulators of the tumor microenvironment. Cell. 141:52–67. 2010. View Article : Google Scholar : PubMed/NCBI
8	Forsyth PA, Wong H, Lainq TD, et al: Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas. Br J Cancer. 79:1828–1835. 1999. View Article : Google Scholar : PubMed/NCBI
9	Hall A: Rho GTPases and the actin cytoskeleton. Science. 279:509–514. 1998. View Article : Google Scholar : PubMed/NCBI
10	Nutt CL, Mani DR, Betensky RA, et al: Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer Res. 63:1602–1607. 2003.PubMed/NCBI
11	Forget MA, Desrosiers RR, Del M, Moumdjian R, Shedid D, Berthelet F and Béliveau R: The expression of rho proteins decreases with human brain tumor progression: Potential tumor markers. Clin Exp Metastasis. 19:9–15. 2002. View Article : Google Scholar : PubMed/NCBI
12	Malchinkhuu E, Sato K, Maehama T, Mogi C, Tomura H, Ishiuchi S, Yoshimoto Y, Kurose H and Okajima F: S1P (2) receptors mediate inhibition of glioma cell migration through Rho signaling pathways independent of PTEN. Biochem Biophys Res Commun. 366:963–968. 2008. View Article : Google Scholar : PubMed/NCBI
13	Goldberg L and Kloog Y: A Ras inhibitor tilts the balance between Rac and Rho and blocks phosphatidylinositol 3-kinasedependent glioblastoma cell migration. Cancer Res. 66:11709–11717. 2006. View Article : Google Scholar : PubMed/NCBI
14	Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, et al: Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 275:218–220. 1997. View Article : Google Scholar : PubMed/NCBI
15	Baur JA and Sinclair DA: Therapeutic potential of resveratrol: The in vivo evidence. Nat Rev Drug Discov. 5:493–506. 2006. View Article : Google Scholar : PubMed/NCBI
16	Brakenhielm E, Cao R and Cao Y: Suppression of angiogenesis, tumour growth and wound healing by resveratrol, a natural compound in red wine and grapes. FASEB J. 15:1798–1800. 2001.PubMed/NCBI
17	Zhang W, Fei Z, Zhen H, Zhang JN and Zhang X: Resveratrol inhibits cell growth and induces apoptosis of rat C6 glioma cells. J Neurooncol. 81:231–240. 2007. View Article : Google Scholar : PubMed/NCBI
18	Lin H, Xiong W, Zhang X, Liu B, Zhang W, Zhang Y, Cheng J and Huang H: Notch-1 activation-dependent p53 restoration contributes to resveratrol-induced apoptosis in glioblastoma cells. Oncol Rep. 26:925–930. 2011.PubMed/NCBI
19	Philip S, Bulbule A and Kundu GC: Matrix metalloproteinase-2: Mechanism and regulation of NF-kappaB-mediated activation and its role in cell motility and ECM-invasion. Glycoconj J. 21:429–441. 2004. View Article : Google Scholar : PubMed/NCBI
20	Matsuoka T, Yashiro M, Kato Y, Shinto O, Kashiwagi S and Hirakawa K: RhoA/ROCK signaling mediates plasticity of scirrhous gastric carcinoma motility. Clin Exp Metastasis. 28:627–636. 2011. View Article : Google Scholar : PubMed/NCBI
21	Giese A, Bjerkvig R, Berens ME and Westphal M: Cost of migration: invasion of malignant gliomas and implications for treatment. J Clin Oncol. 21:1624–1636. 2003. View Article : Google Scholar : PubMed/NCBI
22	Wu H, Liang X, Fang Y, Qin X, Zhang Y and Liu J: Resveratrol inhibits hypoxia-induced metastasis potential enhancement by restricting hypoxia-induced factor-1 alpha expression in colon carcinoma cells. Biomed Pharmacother. 62:613–621. 2008. View Article : Google Scholar : PubMed/NCBI
23	Kundu JK and Surh YJ: Cancer chemopreventive and therapeutic potential of resveratrol: Mechanistic perspectives. Cancer Lett. 269:243–261. 2008. View Article : Google Scholar : PubMed/NCBI
24	Rodrigue CM, Porteu F, Navarro N, Bruyneel E, Bracke M, Romeo PH, Gespach C and Garel MC: The cancer chemopreventive agent resveratrol induces tensin, a cell-matrix adhesion protein with signaling and antitumor activities. Oncogene. 24:3274–3284. 2005. View Article : Google Scholar : PubMed/NCBI
25	EI-Mowafy AM, EI-Mesery ME, Salem HA, Al-Gayyar MM and Darweish MM: Prominent chemopreventive and chemoenhancing effects for resveratrol: Unraveling molecular targets and the role of C-reactive protein. Chemotherapy. 56:60–65. 2010. View Article : Google Scholar : PubMed/NCBI
26	Zhang W, Murao K, Zhang X, Matsumoto K, Diah S, Okada M, Miyake K, Kawai N, Fei Z and Tamiya T: Resveratrol represses YKL-40 expression in human glioma U87 cells. BMC Cancer. 10:5932010. View Article : Google Scholar : PubMed/NCBI
27	Huang H, Lin H, Zhang X and Li J: Resveratrol reverses temozolomide resistance by downregulation of MGMT in T98G glioblastoma cells by the NF-κB-dependent pathway. Onclo Rep. 27:2050–2056. 2012.
28	Libra M, Scalisi A, Vella N, Clementi S, Sorio R, Stivala F, Spandidos DA and Mazzarino C: Uterine cervical carcinoma: Role of matrix metalloproteinases (review). Int J Oncol. 34:897–903. 2009. View Article : Google Scholar : PubMed/NCBI
29	Rao JS, Steck PA, Mohanam S, Stetler-Stevenson WG, Liotta LA and Sawaya R: Elevated levels of M(r) 92,000 type IV collagenase in human brain tumors. Cancer Res. 53(10 Suppl): 2208–2211. 1993.PubMed/NCBI
30	Gabelloni P, Da Pozzo E, Bendinelli S, Costa B, Nuti E, Casalini F, Orlandini E, Da Settimo F, Rossello A and Martini C: Inhibition of metalloproteinases derived from tumours: New insights in the treatment of human glioblastoma. Neurosci. 168:514–522. 2010. View Article : Google Scholar
31	Kim SY, Lee EJ, Woo MS, Jung JS, Hyun JW, Min SW, Kim DH and Kim HS: Inhibition of matrix metalloproteinase-9 gene expression by an isoflavone metabolite, irisolidone in U87MG human astroglioma cells. Biochem Biophys Res Commun. 366:493–499. 2008. View Article : Google Scholar : PubMed/NCBI
32	Gagliano N, Moscheni C, Torri C, Magnani I, Bertelli AA and Gioia M: Effect of resveratrol on matrix metalloproteinase-2 (MMP-2) and secreted protein acidic and rich in cysteine (SPARC) on human cultured glioblastoma cells. Biomed Pharmacother. 59:359–364. 2005. View Article : Google Scholar : PubMed/NCBI
33	Ryu J, Ku BM, Lee YK, Jeong JY, Kang S, Choi J, Yang Y, Lee DH, Roh GS, Kim HJ, et al: Resveratrol reduces TNF-α-induced U373MG human glioma cell invasion through regulating NF-κB activation and uPA/uPAR expression. Anticaner Res. 31:4223–4230. 2011.
34	Guo J, Fan KX, Xie L, Xiao JJ, Chen K, Hui LN and Xu ZH: Effect and prognostic significance of the KAI1 gene in human gastric carcinoma. Oncol Lett. 10:2035–2042. 2015.PubMed/NCBI
35	Nobes CD and Hall A: Rho, rac and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia and filopodia. Cell. 81:53–62. 1995. View Article : Google Scholar : PubMed/NCBI
36	Khalil BD, Hanna S, Saykali BA, El-Sitt S, Nasrallah A, Marston D, El-Sabban M, Hahn KM, Symons M and El-Sibai M: The regulation of RhoA at focal adhesions by StarD13 is important for astrocytoma cell motility. Exp Cell Res. 321:109–122. 2014. View Article : Google Scholar : PubMed/NCBI
37	Salhia B, Rutten F, Nakada M, Beaudry C, Berens M, Kwan A and Rutka JT: Inhibition of Rho-kinase affects astrocytoma morphology, motility and invasion through activation of Rac1. Cancer Res. 65:8792–8800. 2005. View Article : Google Scholar : PubMed/NCBI
38	Cicha I, Regler M, Urschel K, Goppelt-Struebe M, Daniel WG and Garlichs CD: Resveratrol inhibits monocytic cell chemotaxis to MCP-1 and prevents spontaneous endothelial cell migration through Rho kinase-dependent mechanism. J Atheroscler Thromb. 18:1031–1042. 2011. View Article : Google Scholar : PubMed/NCBI
39	Ispanovic E, Serio D and Haas TL: Cdc42 and RhoA have opposing roles in regulating membrane type 1-matrix metalloproteinase localization and matrix metalloproteinase-2 activation. Am J Physiol Cell Physiol. 295:C600–C610. 2008. View Article : Google Scholar : PubMed/NCBI
40	Fromigué O, Hamidouche Z and Marie PJ: Blockade of the RhoA-JNK-c-Jun-MMP2 cascade by atorvastatin reduces osteosarcoma cell invasion. J Biol Chem. 283:30549–30556. 2008. View Article : Google Scholar : PubMed/NCBI